title: Human papillomavirus profile of women in Belize City, Belize: correlation with cervical cytopathologic findings.
abstract: Cervical carcinoma is the most common cancer among Belizean women; however, data regarding the frequency of human papillomavirus (HPV) genotypes and their association with cervical cancer are nonexistent. We therefore included HPV genotyping as part of a week-long cervical cancer screening campaign conducted in Belize City in 2007. Conventional Papanicolaou smears with Hybrid Capture (HC) 2 HPV testing were performed on 463 women. All HC2-positive samples were genotyped using a developmental GP5+/GP6+ polymerase chain reaction-coupled Luminex assay for 2 low-risk and 18 high-risk HPV types. The prevalence of high-risk HPV was 15.6% in the total population, 10.1% in those with normal cytologic findings, and 93.3% in women with a high-grade squamous intraepithelial lesion. Of patients with HPV infections, 35% had multiple types (5.4% of the total group). Of all women and of women with normal cytologic findings, 5.2% and 2.8%, respectively, had HPV16 or 18. For all women, HPV16, 18, 56, and 52 were present in decreasing order of frequency. HPV11 was present in only one patient, and none had HPV6. HPV16 was found in 47% of high-grade squamous epithelial lesions; however, no case of HSIL had HPV18 or 45. HPV35 and HPV58 were the next most common types in high-grade squamous intraepithelial lesion, each occurring in 20% of cases of high-grade squamous intraepithelial lesion, followed by HPV31 in 13.3%. Although women younger than 25 years old were underrepresented, these data suggest that the HPV profile of this cohort of Belizean women differs somewhat from that in the region. In addition, these data are of importance with regard to the development of HPV vaccines that will be used in less developed countries, where care should be taken not to implement vaccination at the cost of basic screening and diagnostic services.
authors.affiliation: Department of Pathology, PO Box 800214, University of Virginia Health System, Charlottesville, VA 22908, USA. hpc4f@virginia.edu
authors.forename: Helen P
authors.initials: HP
authors.lastname: Cathro
authors.forename: Theresa
authors.initials: T
authors.lastname: Loya
authors.forename: Frederick
authors.initials: F
authors.lastname: Dominguez
authors.forename: Susan L
authors.initials: SL
authors.lastname: Howe
authors.forename: Renee
authors.initials: R
authors.lastname: Howell
authors.forename: Kyle
authors.initials: K
authors.lastname: Orndorff
authors.forename: Jessica
authors.initials: J
authors.lastname: Moreno
authors.forename: Elena
authors.initials: E
authors.lastname: Mendez
authors.forename: Po Chu
authors.initials: PC
authors.lastname: Fung
authors.forename: Natalie L
authors.initials: NL
authors.lastname: Beer
authors.forename: Peter
authors.initials: P
authors.lastname: Allen
authors.forename: Alba M
authors.initials: AM
authors.lastname: Sosa
authors.forename: Kelly K
authors.initials: KK
authors.lastname: Gurka
authors.forename: Mark H
authors.initials: MH
authors.lastname: Stoler
authors.forename: Henry F
authors.initials: HF
authors.lastname: Frierson
mesh_terms: D000328:Adult; D001531:Belize / Q000453:epidemiology; D005260:Female; D052162:Human papillomavirus 16 / Q000302:isolation & purification; D052161:Human papillomavirus 18 / Q000302:isolation & purification; D006801:Humans; D065006:Papanicolaou Test; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000235:genetics / Q000821:virology*; D053918:Papillomavirus Vaccines; D015995:Prevalence; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000821:virology*
chemical_list: D053918:Papillomavirus Vaccines